Vitamin E oxidation in human atherosclerotic lesions

Circulation Research

Volumn 90, Issue 3, 2002, Pages 333-339

  Terentis, Andrew C ^a   Thomas, Shane R ^a   Burr, Jeanne A ^b   Liebler, Daniel C ^b   Stocker, Roland ^a  

^a HEART RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

Atherogenesis; Hypochlorous acid; LDL oxidation; Tocopherol

Indexed keywords

5,6 EPOXY ALPHATOCOPHERYLQUINONE DERIVATIVE; ALPHA TOCOPHEROL; ALPHA TOCOPHERYLQUINONE; COPPER DERIVATIVE; HYPOCHLORITE; LOW DENSITY LIPOPROTEIN; NITRITE; OXIDIZING AGENT; PEROXY RADICAL; PEROXYNITRITE; UNCLASSIFIED DRUG;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CONTROLLED STUDY; DISEASE SEVERITY; ELECTRON TRANSPORT; FEMALE; GAS CHROMATOGRAPHY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LIPID OXIDATION; MALE; MASS SPECTROMETRY; MONOCYTE; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; VITAMIN METABOLISM;

ADULT; AORTA; ARTERIOSCLEROSIS; CAROTID ARTERIES; CHLORIDES; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; MONOCYTES; NITRITES; OXIDANTS; OXIDATION-REDUCTION; TETRADECANOYLPHORBOL ACETATE; VITAMIN E;

EID: 0037155055     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/hh0302.104454     Document Type: Article

References (39)

1. Beyond cholesterol: Modifications of low-density lipoprotein that increase its atherogenicity
2. 2-isoprostanes in human atherosclerotic lesions
3. Human atherosclerotic plaque contains both oxidized lipids and relatively large amounts of α-tocopherol and ascorbate
4. Co-existence of oxidized lipids and α-tocopherol in all lipoprotein fractions isolated from advanced human atherosclerotic plaques
5. 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima
6. Reactive nitrogen intermediates promote low density lipoprotein oxidation in human atherosclerotic intima
7. Oxidants and antioxidants in the pathogenesis of atherosclerosis: Implications for the oxidized low density lipoprotein hypothesis
8. The ambivalence of vitamin E in atherogenesis
9. Tocopherol-mediated peroxidation: The pro-oxidant effect of vitamin E on the radical-initiated oxidation of human low-density lipoprotein
10. Prevention of tocopherol-mediated peroxidation of ubiquinol-10-free human low density lipoprotein
11. Tocopherol-mediated peroxidation (TMP) of lipoproteins: Implications for vitamin E as a potential anti-atherogenic supplement
12. Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in apoE-deficient mice
13. Rapid isolation of lipoproteins and assessment of their peroxidation by HPLC postcolumn chemiluminescence
14. Assessment of pro- and anti-oxidant activity of vitamin E in human low density lipoprotein and plasma
15. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis: A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association
16. Requirement for, promotion, or inhibition by α-tocopherol of radical-induced initiation of plasma lipoprotein lipid peroxidation
17. Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro
18. Gas chromatography-mass spectrometry analysis of vitamin E and its oxidation products
19. 2-isoprostanes) in plasma and low-density lipoprotein exposed to oxidative stress in vitro
20. Pro-oxidant effects of lipoxygenase-derived peroxides on the copper-initiated oxidation of low-density lipoprotein
21. Formation of reactive nitrogen species during peroxidase-catalyzed oxidation of nitrite: A potential additional mechanism of nitric oxide-dependent toxicity
22. Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils
23. Formation of nitric oxide-derived oxidants by myeloperoxidase in monocytes: Pathways for monocyte-mediated protein nitration and lipid peroxidation in vivo
24. Elevated levels of protein-bound p-hydroxyphenylacetaldehyde, an amino acid-derived aldehyde generated by myeloperoxidase, are present in human fatty streaks, intermediate lesions and advanced atherosclerotic lesions
25. Vitamin E: Application of the principles of physical organic chemistry to the exploration of its structure and function
26. α-tocopherol does not inhibit hypochlorite-induced oxidation of apolipoprotein B-100 of low-density lipoprotein
27. The oxidation of α-tocopherol and trolox by peroxynitrite
28. Secondary radicals derived from chloramines of apolipoprotein B-100 contribute to HOC-induced lipid per-oxidation of low-density lipoproteins
29. NAD(P)H oxidase: Role in cardiovascular biology and disease
30. Extensive nitration of protein tyrosine in human atherosclerosis detected by immunohistochemistry
31. Potential antiatherogenic mechanisms of ascorbate (vitamin C) and α-tocopherol (vitamin E)
32. Presence of hypochlorite-modified proteins in human atherosclerotic lesions
33. Formation of nitrating and chlorinating species by reaction of nitrite with hypo-chlorous acid: A novel mechanism for nitric oxide-mediated protein modification
34. Myeloperoxidase and horse-radish peroxidase catalyze tyrosine nitration in proteins from nitrite and hydrogen peroxide
35. Inhibition by a co-antioxidant of aortic lipoprotein lipid peroxidation and atherosclerosis in apolipoprotein E and low density lipoprotein receptor gene double knockout mice
36. 10 in apolipoprotein E gene knockout mice
37. 10 inhibits atherosclerosis in apolipoprotein E gene knockout mice
38. Effects of UV light and tumor promoters on endogenous vitamin E status in mouse skin
39. 13C-NMR study